⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for brain stem glioma

Every month we try and update this database with for brain stem glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22NCT01884740
Glioblastoma Mu...
Fibrillary Astr...
Glioma of Brain...
Anaplastic Astr...
Pilomyxoid Astr...
Mixed Oligodend...
Brain Stem Glio...
Diffuse Intrins...
SIACI of Erbitu...
1 Year - 21 YearsWeill Medical College of Cornell University
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22NCT01884740
Glioblastoma Mu...
Fibrillary Astr...
Glioma of Brain...
Anaplastic Astr...
Pilomyxoid Astr...
Mixed Oligodend...
Brain Stem Glio...
Diffuse Intrins...
SIACI of Erbitu...
1 Year - 21 YearsWeill Medical College of Cornell University
Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem GliomaNCT02887040
Brain Stem Glio...
Radiation
Atengenal
Astugenal
3 Years - 99 YearsBurzynski Research Institute
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2NCT01082926
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Meni...
Anaplastic Olig...
Brain Stem Glio...
Ependymoblastom...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Grade III Menin...
Meningeal Heman...
Mixed Glioma
Pineal Gland As...
Brain Tumor
therapeutic all...
aldesleukin
laboratory biom...
positron emissi...
18 Years - 70 YearsCity of Hope Medical Center
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaNCT01095094
Brain Tumor
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Olig...
Brain Stem Glio...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Mixed Glioma
ritonavir
lopinavir
18 Years - Case Comprehensive Cancer Center
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsNCT00003926
Brain and Centr...
Childhood Germ ...
Chordoma
Kidney Cancer
Liver Cancer
Neuroblastoma
Ovarian Cancer
Retinoblastoma
Sarcoma
amifostine trih...
busulfan
filgrastim
melphalan
thiotepa
peripheral bloo...
1 Year - 45 YearsMasonic Cancer Center, University of Minnesota
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasNCT01514201
Anaplastic Astr...
Brain Stem Glio...
Childhood Mixed...
Fibrillary Astr...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
3-Dimensional C...
Intensity-Modul...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
- 21 YearsNational Cancer Institute (NCI)
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsNCT00003926
Brain and Centr...
Childhood Germ ...
Chordoma
Kidney Cancer
Liver Cancer
Neuroblastoma
Ovarian Cancer
Retinoblastoma
Sarcoma
amifostine trih...
busulfan
filgrastim
melphalan
thiotepa
peripheral bloo...
1 Year - 45 YearsMasonic Cancer Center, University of Minnesota
A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the BrainNCT01403311
Glioma
5-Aminolevuline...
18 Years - Legacy Health System
Immunotherapy for Patients With Brain Stem Glioma and GlioblastomaNCT00576641
Brain Stem Glio...
Glioblastoma
autologous dend...
- Cedars-Sinai Medical Center
Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem GliomaNCT02887040
Brain Stem Glio...
Radiation
Atengenal
Astugenal
3 Years - 99 YearsBurzynski Research Institute
Antineoplaston Therapy in Treating Children With Brain TumorsNCT00003458
Childhood Brain...
Antineoplaston ...
6 Months - 18 YearsBurzynski Research Institute
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasNCT01514201
Anaplastic Astr...
Brain Stem Glio...
Childhood Mixed...
Fibrillary Astr...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
3-Dimensional C...
Intensity-Modul...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
- 21 YearsNational Cancer Institute (NCI)
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem GliomaNCT00179881
Brain Stem Neop...
Neoplasms, Brai...
Carboplatin
Thalomid
External Beam R...
3 Years - 21 YearsAnn & Robert H Lurie Children's Hospital of Chicago
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaNCT01236560
Brain Stem Glio...
Cerebral Astroc...
Childhood Cereb...
Childhood Cereb...
Childhood Spina...
Bevacizumab
Temozolomide
Vorinostat
3 Years - 21 YearsNational Cancer Institute (NCI)
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)NCT03396575
Diffuse Intrins...
Brain Stem Glio...
TTRNA-DC vaccin...
TTRNA-xALT
Cyclophosphamid...
Dose-Intensifie...
Td vaccine
Autologous Hema...
3 Years - 30 YearsUniversity of Florida
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsNCT01682746
Brain Tumor, Re...
Photofrin (porf...
6 Months - 18 YearsMedical College of Wisconsin
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsNCT01682746
Brain Tumor, Re...
Photofrin (porf...
6 Months - 18 YearsMedical College of Wisconsin
Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem GliomaNCT02887040
Brain Stem Glio...
Radiation
Atengenal
Astugenal
3 Years - 99 YearsBurzynski Research Institute
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsNCT01682746
Brain Tumor, Re...
Photofrin (porf...
6 Months - 18 YearsMedical College of Wisconsin
Antineoplaston Therapy in Treating Children With Brain TumorsNCT00003458
Childhood Brain...
Antineoplaston ...
6 Months - 18 YearsBurzynski Research Institute
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasNCT01514201
Anaplastic Astr...
Brain Stem Glio...
Childhood Mixed...
Fibrillary Astr...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
3-Dimensional C...
Intensity-Modul...
Laboratory Biom...
Pharmacological...
Temozolomide
Veliparib
- 21 YearsNational Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: